"Outpatient leucovorin prescriptions for children ages five to 17 in the US rose by 71% in the weeks following the announcement, new research shows."
"Marty Makary, commissioner of the US Food and Drug Administration (FDA), said in a statement that the treatment seems to help treat developmental delays with autistic features."
"Hundreds of thousands of kids, in my opinion, will benefit, he said, stating that being autistic may be entirely preventable."
"Other officials also spoke to the potential benefits of leucovorin for autism, giving hope to many parents with autistic children."
Following a press conference where leucovorin was touted as a treatment for autism, outpatient prescriptions for children surged by 71%. Despite the FDA's approval of leucovorin only for cerebral folate deficiency, officials previously claimed it could benefit many autistic children. The FDA commissioner suggested that a significant percentage of children with autism might see improvements with leucovorin. However, the lack of evidence supporting its efficacy for autism raises concerns among medical professionals and parents alike.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]